Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion type Assertion NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_head.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion evidence source_evidence_literature NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion SIO_000772 15987444 NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion wasDerivedFrom lhgdn-20090331 NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion wasGeneratedBy ECO_0000203 NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.